Skip to main content

The Wistar Institute

|

Why this Wistar Scientist sees hope for an HIV cure

Dr. Luis J. Montaner, D.V.M., D. Phil., is the Herbert Kean, M.D., Family Professor; vice president of Scientific Operations; associate director for Shared Resources at the Ellen and Ronald Caplan Cancer Center; director of the HIV-1 Immunopathogene…
Read more
|

The Wistar Institute Receives $10 Million Donation

PHILADELPHIA — (June 18, 2024) — The Wistar Institute received a $10 million donation from an anonymous donor who previously committed $20 million to support Wistar’s new Center for Advanced Therapeutics. This now $30 million gift to Wistar’s Bold S…
Read more
|

Research in the Classroom: Wistar and Collaborators Enhance Experiential Learning in The Life Science Classrooms of G.W. Carver High School

[pictured: George Washington Carver High School students observe Wistar’s Andrew Milcarek, Ph.D. in the lab] Philadelphia’s George Washington Carver High School of Engineering and Science is a criteria-based admission school that enrolls stude…
Read more
|

Wistar Scientists Develop Novel Antibody Treatment for Kidney Cancer

PHILADELPHIA — (June 04, 2024) — Advanced clear cell renal cell carcinoma (ccRCC) is a deadly form of kidney cancer with few treatment options; even with new immunotherapies, only around one in 10 patients ultimately survive.
Read more
|

Wistar Research Identifies Mechanisms for Selective Multiple Sclerosis Treatment Strategy

PHILADELPHIA — (May 28, 2024) — The Wistar Institute’s Paul M. Lieberman, Ph.D., and lab team led by senior staff scientist and first author, Samantha Soldan, Ph.D., have demonstrated how B cells infected with the Epstein-Barr virus (EBV) can contri…
Read more
|

Wistar Melanoma Researchers Discuss Risks and Solutions for Melanoma Awareness Month

Three of The Wistar Institute’s foremost melanoma researchers: professor Meenhard Herlyn, D.V.M., D.Sc.; associate professor Jessie Villanueva, Ph.D.; and assistant professor Noam Auslander, Ph.D. discussed the progress and potential in melanoma res…
Read more
|

Revealing Biology’s Hidden Patterns: Wistar’s Dr. Noam Auslander on the Power and Potential of Machine Learning

Dr. Noam Auslander, Ph.D., is assistant professor of the Molecular and Cellular Oncogenesis Program at the Ellen and Ronald Caplan Cancer Center. She focuses on developing machine learning methods to understand the factors driving cancer development…
Read more
|

Wistar Scientists Discover New Immunosuppressive Mechanism in Brain Cancer

PHILADELPHIA — (May 3, 2024) — The Wistar Institute assistant professor Filippo Veglia, Ph.D., and team, have discovered a key mechanism of how glioblastoma — a serious and often fatal brain cancer — suppresses the immune system so that the tumor ca…
Read more
|

The Wistar Institute and Collaborators Celebrate Two New Cohorts of Philly’s Life Science Workforce

University City, Philadelphia may have been quieter than usual with so many taking spring breaks, but March was a busy month for The Wistar Institute’s Hubert J.P. Schoemaker Education and Training Center: not one but two cohorts of the Institute’s…
Read more
|

Promising Personalized Approach to Liver Cancer Therapy Made Possible by DNA-based Neoantigen Research Designed at The Wistar Institute

PHILADELPHIA — (Tuesday, April 30, 2024) — Hepatocellular carcinoma (HCC), or liver cancer, is an aggressive malignancy with limited treatment options. An immunologically cold cancer — meaning the tumors can effectively hide themselves from the immu…
Read more